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DRUG-RESISTANT 
SALMONELLA SEROTYPE TYPHI 
THREAT LEVEL SERIOUS
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each year
Salmonella Typhi bacteria cause typhoid fever, a potentially life-threatening disease. Symptoms include high 
fever, abdominal pain, and headache. Infection can lead to bowel rupture, shock, and death. 
WHAT YOU NEED TO KNOW
 ■ Salmonella Typhi causes an estimated 5,700 infections 
and 620 hospitalizations each year in the United States. 
Worldwide, an estimated 11 to 21 million infections occur 
each year. 
 ■ Typhoid fever requires treatment with antibiotics, which 
is complicated by increasing resistance.
 ■ Most people in the United States become infected while 
traveling to countries where the disease is common 
(places with poor sanitation and lack of safe drinking 
water). Vaccination before travel to countries where the 
disease is common may prevent typhoid fever.
RESISTANCE OVER TIME
The percent of Salmonella Typhi infections nonsusceptible to 
ciprofloxacin reached 74% in 2017, severely limiting treatment options. 
0%
10%
20%
30%
40%
50%
60%
70%
80%
Pe
rc
en
ta
ge
 o
f S
al
m
on
el
la
 T
yp
hi
 Is
ol
at
es
*
N
on
su
sc
ep
tib
le
 t
o 
C
ip
ro
flo
xa
ci
n
22%
74%
1999 2001 2003 2005 2007 2009 2011 2013 2015 2017
*Isolates are pure samples of a germ 
DRUG-RESISTANT SALMONELLA SEROTYPE TYPHI
XDR TYPHOID FEVER IN TRAVELERS 
Over the past decade, several strains (types) of 
Salmonella Typhi have become resistant to multiple 
antibiotics. One recently emerging strain of extensively 
drug-resistant (XDR) Salmonella Typhi is resistant to all 
but two antibiotic classes recommended for treatment 
(macrolides and carbapenems). Since 2016, an ongoing 
outbreak of XDR typhoid fever has sickened more than 
5,000 people in Pakistan, and 11 children in the United 
States who traveled to or from Pakistan. 
CDC is working with public health partners across 
the globe, including Pakistani health authorities, to 
strengthen prevention efforts, including vaccination.  
In the United States, healthcare providers, state and 
local public health officials, and scientists at CDC 
are closely monitoring emerging resistance among 
Salmonella Typhi strains to identify it quickly and ensure 
that patients get appropriate antibiotic treatment. 
Without improved sanitation and access to safe drinking 
water, this germ and its resistance will continue to pose 
a risk and spread. U.S. travelers should get vaccinated 
before going to areas where the disease is common. 
RESISTANCE SNAPSHOT
Salmonella Typhi strains are often nonsusceptible to 
ciprofloxacin, so antibiotic treatment options are diminishing. 
CIPROFLOXACIN 
NONSUSCEPTIBLE
PERCENTAGE OF  
ALL SALMONELLA TYPHI* 71%
ESTIMATED NUMBER OF 
INFECTIONS PER YEAR 4,100
ESTIMATED INFECTIONS 
PER 100,000  
U.S. POPULATION
Less than 5
Antibiotic susceptibility helps describe how sensitive germs are to particular 
antibiotics. An antibiotic can stop the growth of or kill a susceptible germ.
*Average (2015–2017)
ONLINE RESOURCES
About Typhoid fever 
www.cdc.gov/Typhoid-Fever
CDC’s MMWR Publication on Emergence of XDR Salmonella
Typhi Infections Among Travelers
www.cdc.gov/MMWR/Volumes/68/wr/mm6801a3.htm
This fact sheet is part of CDC’s 2019 Antibiotic Resistance Threats Report.  
The full report, including data sources, is available at www.cdc.gov/DrugResistance/Biggest-Threats.html.
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